STOCKHOLM, Sweden, May 2, 2005 (PRIMEZONE) -- Artimplant:
-- Artimplant's net sales for the period reached SEK 1.1 million
(SEK 1.0 million)
-- Losses after tax was SEK 9.1 million (SEK 6.6 million)
-- The loss per share was SEK 0.23 (SEK 0.17)
-- ARTELON TMC Spacer was launched by Small Bone Innovations (Avanta
Orthopaedics) at AAOS -- American Academy of Orthopaedic Surgeons
-- in Washington DC
-- Artimplant expands into new product areas, Odontology and
Craiomaxillofacial surgery and conducts a rights issue.
Institutional investors have through guarantees and letters of
intent committed to subscribe to shares corresponding to 92% of
the issue
This information was brought to you by Waymaker http://www.waymaker.net
The full report is available for download:
http://wpy.waymaker.net/client/waymaker1/WOLReleaseFile.aspx?id=94429&fn=wkr0001.pdf